Global Overactive Bladder Treatment Market Research Report 2011-2023
- HEY2248082
- 86 Pages
- November 2017
- Healthcare
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
The global Overactive Bladder Treatment market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Anticholinergics
Mirabegron
Botox
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Anticholinergics
1.2.1.2 Mirabegron
1.2.1.3 Botox
1.2.2 by Application
1.2.2.1 Idiopathic Overactive Bladder
1.2.2.2 Neurogenic Overactive Bladder
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Anticholinergics Market, 2011-2016
4.1.2 Mirabegron Market, 2011-2016
4.1.3 Botox Market, 2011-2016
4.2 Market Forecast
4.2.1 Anticholinergics Market Forecast, 2017-2022
4.2.2 Mirabegron Market Forecast, 2017-2022
4.2.3 Botox Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Idiopathic Overactive Bladder Market, 2011-2016
5.1.2 Neurogenic Overactive Bladder Market, 2011-2016
5.2 Market Forecast
5.2.1 Idiopathic Overactive Bladder Market Forecast, 2017-2022
5.2.2 Neurogenic Overactive Bladder Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Astellas Pharma
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Allergan
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Pfizer
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Teva (Activas)
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Johnson & Johnson
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Overactive Bladder Treatment
Table Products Segment of Overactive Bladder Treatment
Table Anticholinergics Overview
Table Mirabegron Overview
Table Botox Overview
Table Global Overactive Bladder Treatment Market by Type, 2011-2022 (USD Million)
Table Application Segment of Overactive Bladder Treatment
Table Idiopathic Overactive Bladder Overview
Table Neurogenic Overactive Bladder Overview
Table Global Overactive Bladder Treatment Market by Application, 2011-2022 (USD Million)
Table Global Overactive Bladder Treatment Market by Region, 2011-2022 (USD Million)
Table Cost of Overactive Bladder Treatment
Table Market Dynamics
Table Policy of Overactive Bladder Treatment
Table GDP of Major Countries
Table Anticholinergics CAGR by Revenue and Volume, 2011-2016
Table Mirabegron CAGR by Revenue and Volume, 2011-2016
Table Botox CAGR by Revenue and Volume, 2011-2016
Table Anticholinergics CAGR by Revenue and Volume, 2012-2022
Table Mirabegron CAGR by Revenue and Volume, 2012-2022
Table Botox CAGR by Revenue and Volume, 2012-2022
Table Idiopathic Overactive Bladder CAGR by Revenue and Volume, 2011-2016
Table Neurogenic Overactive Bladder CAGR by Revenue and Volume, 2011-2016
List Of Figures
Figure Overactive Bladder Treatment Picture
Figure Industry Chain Structure of Overactive Bladder Treatment
Figure SWOT of Overactive Bladder Treatment
Figure Anticholinergics Market Size and Growth, 2011-2016 (USD Million)
Figure Anticholinergics Market Size and Growth, 2011-2016 (in Volume)
Figure Mirabegron Market Size and Growth, 2011-2016 (USD Million)
Figure Mirabegron Market Size and Growth, 2011-2016 (in Volume)
Figure Botox Market Size and Growth, 2011-2016 (USD Million)
Figure Botox Market Size and Growth, 2011-2016 (in Volume)
Figure Anticholinergics Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Anticholinergics Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Mirabegron Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Mirabegron Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Botox Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Botox Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Idiopathic Overactive Bladder Market Size and Growth, 2011-2016 (USD Million)
Figure Idiopathic Overactive Bladder Market Size and Growth, 2011-2016 (in Volume)
Figure Neurogenic Overactive Bladder Market Size and Growth, 2011-2016 (USD Million)
Figure Neurogenic Overactive Bladder Market Size and Growth, 2011-2016 (in Volume)
Figure Idiopathic Overactive Bladder Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Idiopathic Overactive Bladder Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Neurogenic Overactive Bladder Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Neurogenic Overactive Bladder Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Overactive Bladder Treatment Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
